PRIMORIS      Contacts      FAQs      INSTICC Portal
 

Special Sessions

Special sessions are very small and specialized events to be held during the conference as a set of oral and poster presentations that are highly specialized in some particular theme or consisting of the works of some particular international project. The goal of special sessions (minimum 4 papers; maximum 9) is to provide a focused discussion on innovative topics. All accepted papers will be published in a special section of the conference proceedings book, under an ISBN reference, and on CD-ROM support. All papers presented at the conference venue will be available at the SCITEPRESS Digital Library. SCITEPRESS is a member of CrossRef and every paper is given a DOI (Digital Object Identifier). The proceedings are submitted for indexation by Thomson Reuters Conference Proceedings Citation Index (ISI), INSPEC, DBLP, EI (Elsevier Engineering Village Index) and Scopus.


SPECIAL SESSIONS LIST

SmartMedDev 2016Special Session on Smart Medical Devices - From Lab to Clinical Practice
Chair(s): Jan Sliwa, Giovanna Sannino and Ivanoe De Falco

Special Session on Smart Medical Devices - From Lab to Clinical Practice - SmartMedDev 2016



Co-chairs

Jan Sliwa
Bern University of Applied Sciences
Switzerland
e-mail
 
Giovanna Sannino
Institute for High-Performance Computing and Networking
Italy
e-mail
 
Ivanoe De Falco
CNR - ICAR
Italy
e-mail
 
Scope

The goal of this special session is to discuss the problems hindering the widespread adoption of smart medical devices - software based, wireless, implantable and wearable. Many brilliant ideas remain at the level of the proof of concept and never reach the market or the clinical practice.
We focus on high-safety health monitoring and life saving devices. We are especially interested in sets of heterogeneous devices aggregated around a common communication platform (smartphone), based on open standards. In our opinion, aside of technical problems, the adoption of such systems is restrained by organizational issues, like incorporating in therapies applied by hospitals and reimbursed by insurances. This may need a formal approval and calls for a well-organized quality monitoring.



footer